RWC Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CS
RWC Asset Management's IBB Position: Q1 2017 in Review
RWC Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 2,565 shares — an estimated $227K sold.
RWC Asset Management first reported a position in IBB in Q2 2016 and held it in 3 quarters. The position peaked at $333K in Q3 2016. 520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.
- RWC Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
- RWC Asset Management sold 2,565 iShares Biotechnology ETF shares in Q1 2017, an estimated $227K.
- RWC Asset Management first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 3 quarters.
- RWC Asset Management's iShares Biotechnology ETF position peaked at $333K in Q3 2016.
- 520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.
Based on RWC Asset Management's 13F filing for Q1 2017, filed 9 May 2017.